TCT-344 Clinical Outcomes of Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients Stratified by STS Score: Results from the SURTAVI Trial

Background The Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial randomized patients with severe, symptomatic aortic stenosis deemed intermediate-risk for surgical mortality by heart team assessment. Valvular Disease: Aortic Variable, mean±SD or % STS

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B141-B142
Main Authors: Serruys, Patrick, Abdelghani, Mohammad, Popma, Jeffrey J., Reardon, Michael J., Kleiman, Neal, Crestanello, Juan, Lillly, Scott, Van Boven, Ad, Willem Boonstra, Piet, Piazza, Nicolo, Van Mieghem, Nicolas, Kappetein, A. Pieter
Format: Article
Language:English
Subjects:
Aortic stenosis
Cardiology
Clinical outcomes
Diabetes mellitus
Implantation
Mortality
Rheumatic heart disease
Surgery
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial randomized patients with severe, symptomatic aortic stenosis deemed intermediate-risk for surgical mortality by heart team assessment. Valvular Disease: Aortic Variable, mean±SD or % STS
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.435